Overview

Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the within-subject variation in duration of action and time-action profile of glargine measured by isoglycemic clamp will be below prespecified levels.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc